Market Research Logo

Global Platinum based Cancer Drug Market Research Report 2018

Global Platinum based Cancer Drug Market Research Report 2018

This report studies the Platinum based Cancer Drug market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Platinum based Cancer Drug market by product type and applications/end industries.

In the last several years, global market of platinum based cancer drug developed smoothly, with an average growth rate of 4.29%. In 2017, global revenue of platinum based cancer drug is nearly 1285 M USD; the actual sales are about 27572 K units.

The major players in global Platinum based Cancer Drug market include
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Platinum based Cancer Drug in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa

On the basis of product, the Platinum based Cancer Drug market is primarily split into
Cisplatin
Oxaliplatin
Carboplatin
Other

On the basis on the end users/applications, this report covers
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Other


1 Platinum based Cancer Drug Market Overview
1.1 Platinum based Cancer Drug Product Overview
1.2 Platinum based Cancer Drug Segment by Types (Product Category)
1.2.1 Global Platinum based Cancer Drug Sales by Types
1.2.2 Global Platinum based Cancer Drug Sales Market Share by Types in 2017
1.2.3 Cisplatin
1.2.4 Oxaliplatin
1.2.5 Carboplatin
1.3 Global Platinum based Cancer Drug Segment by Applications
1.3.1 Global Platinum based Cancer Drug Sales Comparison by Applications
1.3.2 Colorectal Cancer
1.3.3 Ovarian Cancer
1.3.4 Lung Cancer
1.4 Global Platinum based Cancer Drug Market by Regions (2013-2025)
1.4.1 Global Platinum based Cancer Drug Market Size Comparison by Regions (2013-2025)
1.4.2 North America Platinum based Cancer Drug Status and Prospect (2013-2025)
1.4.3 Europe Platinum based Cancer Drug Status and Prospect (2013-2025)
1.4.4 Asia-Pacific Platinum based Cancer Drug Status and Prospect (2013-2025)
1.4.5 South America Platinum based Cancer Drug Status and Prospect (2013-2025)
1.4.6 Middle East & Africa Platinum based Cancer Drug Status and Prospect (2013-2025)
1.5 Global Platinum based Cancer Drug Market Size (2013-2025)
1.5.1 Global Platinum based Cancer Drug Revenue Status and Outlook (2013-2025)
1.5.2 Global Platinum based Cancer Drug Sales Status and Outlook (2013-2025)
2 Global Platinum based Cancer Drug Market Competition by Manufacturers
2.1 Global Platinum based Cancer Drug Sales and Share by Manufacturers (2017-2018)
2.2 Global Platinum based Cancer Drug Revenue and Share by Manufacturers (2017-2018)
2.3 Global Platinum based Cancer Drug Average Price by Manufacturers (2017-2018)
2.4 Manufacturers Platinum based Cancer Drug Headquarters and Established
2.5 Platinum based Cancer Drug Market Competitive Situation and Trends
2.5.1 Platinum based Cancer Drug Market Concentration Rate
2.5.2 Platinum based Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Platinum based Cancer Drug Sales by Regions (2013-2018)
3.1 Global Platinum based Cancer Drug Sales and Market Share by Regions (2013-2018)
3.2 Global Platinum based Cancer Drug Revenue and Market Share by Regions (2013-2018)
3.3 Global Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)
3.4 North America Platinum based Cancer Drug Sales (2013-2018)
3.4.1 North America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
3.4.2 North America Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)
3.5 Europe Platinum based Cancer Drug Sales (2013-2018)
3.5.1 Europe Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
3.5.2 Europe Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)
3.6 Asia-Pacific Platinum based Cancer Drug Sales (2013-2018)
3.6.1 Asia-Pacific Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
3.6.2 Asia-Pacific Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)
3.7 South America Platinum based Cancer Drug Sales (2013-2018)
3.7.1 South America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
3.7.2 South America Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)
3.8 Middle East & Africa Platinum based Cancer Drug Sales (2013-2018)
3.8.1 Middle East & Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
3.8.2 Middle East & Africa Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)
4 Global Platinum based Cancer Drug Sales, Revenue (Value), Price Trend by Types
4.1 Global Platinum based Cancer Drug Sales and Market Share by Types (2013-2018)
4.2 Global Platinum based Cancer Drug Revenue and Market Share by Types (2013-2018)
4.3 Global Platinum based Cancer Drug Price by Types (2013-2018)
4.4 Global Platinum based Cancer Drug Sales Growth Rate by Types (2013-2018)
5 Global Platinum based Cancer Drug Market Analysis by Applications
5.1 Global Platinum based Cancer Drug Sales and Market Share by Applications (2013-2018)
5.2 Global Platinum based Cancer Drug Sales Growth Rate by Applications (2013-2018)
6 Analysis of Platinum based Cancer Drug Industry Key Manufacturers
6.1 Sanofi
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 Hengrui Medicine
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 ASK Pharma
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Cost, Gross, and Revenue
6.4 Yi Bai Pharmaceutical
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Cost, Gross, and Revenue
6.5 Qilu Pharmaceutical
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Sales, Price, Cost, Gross, and Revenue
6.6 Teva
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Sales, Price, Cost, Gross, and Revenue
6.7 Pfizer
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Sales, Price, Cost, Gross, and Revenue
6.8 Dr Reddy¡¯s Laboratories
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Sales, Price, Cost, Gross, and Revenue
6.9 Mylan
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Sales, Price, Cost, Gross, and Revenue
6.10 Sun Pharma
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Sales, Price, Cost, Gross, and Revenue
6.11 Novartis
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Sales, Price, Cost, Gross, and Revenue
6.12 Debiopharm
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Sales, Price, Cost, Gross, and Revenue
6.13 Accord Healthcare
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Sales, Price, Cost, Gross, and Revenue
6.14 SK Chemicals
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 Sales, Price, Cost, Gross, and Revenue
7 Platinum based Cancer Drug Manufacturing Cost Analysis
7.1 Platinum based Cancer Drug R&D Cost Analysis
7.1.1Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.2.1 USA Labor Cost Analysis
7.2.2.2 Europe Labor Costs Analysis
7.2.2.3 Asia Labor Costs Analysis
7.2.3 Other Costs Analysis
7.2.3.1 USA Cost of Electricity Analysis
7.2.3.2 USA Water Cost Analysis
7.2.3.3 Europe Cost of Electricity Analysis
7.2.3.4 Europe Water Cost Analysis
7.2.3.5 China Cost of Electricity Analysis
7.2.3.6 China Water Cost Analysis
7.3 Manufacturing Process Analysis of Platinum based Cancer Drug
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Platinum based Cancer Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 New Active Substance Launches 2011-2015 by Indication
10.1.2 Rapid Uptake of New Immune-oncology Drugs Reflects Their Remarkable Clinical Profile and Expansion of Indications
10.1.3 Technology Progress in Related Industry
10.2 Cancer Patients Analysis
10.2.1 Key Facts
10.2.2 Cancer Incidence and Mortality Analysis
10.3 Economic/Political Environmental Change
11 Global Platinum based Cancer Drug Market Forecast (2019-2025)
11.1 Global Platinum based Cancer Drug Sales, Revenue Forecast (2019-2025)
11.1.1 Global Platinum based Cancer Drug Sales and Growth Rate Forecast (2019-2025)
11.1.2 Global Platinum based Cancer Drug Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Platinum based Cancer Drug Price and Trend Forecast (2019-2025)
11.2 Global Platinum based Cancer Drug Sales Forecast by Regions (2019-2025)
11.2.1 North America Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)
11.2.2 Europe Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)
11.2.3 Asia-Pacific Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)
11.2.4 South America Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)
11.2.5 Middle East & Africa Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)
11.3 Global Platinum based Cancer Drug Revenue Forecast by Regions (2019-2025)
11.3.1 North America Platinum based Cancer Drug Revenue Forecast (2019-2025)
11.3.2 Europe Platinum based Cancer Drug Revenue Forecast (2019-2025)
11.3.3 Asia-Pacific Platinum based Cancer Drug Revenue Forecast (2019-2025)
11.3.4 South America Platinum based Cancer Drug Revenue Forecast (2019-2025)
11.3.5 Middle East & Africa Platinum based Cancer Drug Revenue Forecast (2019-2025)
11.4 Global Platinum based Cancer Drug Sales, Revenue and Price Forecast by Types (2019-2025)
11.4.1 Global Platinum based Cancer Drug Sales Forecast by Types (2019-2025)
11.4.2 Global Platinum based Cancer Drug Revenue Forecast by Types (2019-2025)
11.4.3 Global Platinum based Cancer Drug Price Forecast by Types (2019-2025)
11.5 Global Platinum based Cancer Drug Sales Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Product Picture of Platinum based Cancer Drug
Table Global Platinum based Cancer Drug Sales (K Unit) Comparison by Types (2013-2025)
Figure Global Platinum based Cancer Drug Sales Market Share by Types in 2017
Figure Product Picture of Cisplatin
Figure Product Picture of Oxaliplatin
Figure Product Picture of Carboplatin
Table Global Platinum based Cancer Drug Sales (K Unit) Comparison by Applications (2013-2025)
Figure Global Platinum based Cancer Drug Sales Market Share by Applications in 2017
Figure Colorectal Cancer Examples
Figure Ovarian Cancer Examples
Figure Lung Cancer Examples
Table Global Platinum based Cancer Drug Market Size (M USD) Comparison by Regions (2013-2025)
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)
Figure Global Platinum based Cancer Drug Revenue (M USD) Status and Outlook (2013-2025)
Figure Global Platinum based Cancer Drug Sales (K Unit) Status and Outlook (2013-2025)
Table Global Platinum based Cancer Drug Sales (K Unit) of Key Manufacturers (2017-2018)
Table Global Platinum based Cancer Drug Sales Market Share by Manufacturers (2017-2018)
Figure 2017 Platinum based Cancer Drug Sales Market Share by Manufacturers
Figure 2018 Platinum based Cancer Drug Sales Market Share by Manufacturers
Table Global Platinum based Cancer Drug Revenue (M USD) by Manufacturers (2017-2018)
Table Global Platinum based Cancer Drug Revenue Share by Manufacturers (2017-2018)
Figure 2017 Global Platinum based Cancer Drug Revenue Share by Manufacturers
Figure 2018 Global Platinum based Cancer Drug Revenue Share by Manufacturers
Table Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers (2017-2018)
Figure Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Platinum based Cancer Drug Headquarters and Established
Figure 2017 Platinum based Cancer Drug Revenue Market Share by Manufacturers
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 3 Manufacturers
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 5 Manufacturers
Table Global Platinum based Cancer Drug Sales (K Unit) by Regions (2013-2018)
Table Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018)
Figure Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018)
Figure 2017 Global Platinum based Cancer Drug Sales Market Share by Regions
Table Global Platinum based Cancer Drug Revenue (M USD) by Regions (2013-2018)
Table Global Platinum based Cancer Drug Revenue Market Share by Regions (2013-2018)
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions (2013-2018)
Figure 2017 Global Platinum based Cancer Drug Revenue Market Share by Regions
Figure Global Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)
Table Global Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Figure North America Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)
Table North America Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Figure Europe Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)
Table Europe Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)
Table Asia-Pacific Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Figure South America Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)
Table South America Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Figure Middle East & Africa Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)
Table Middle East & Africa Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Table Global Platinum based Cancer Drug Sales (K Unit) by Types (2013-2018)
Table Global Platinum based Cancer Drug Sales Market Share by Types (2013-2018)
Figure Sales Market Share of Platinum based Cancer Drug by Types (2013-2018)
Figure 2017 Sales Market Share of Platinum based Cancer Drug by Types
Table Global Platinum based Cancer Drug Revenue (M USD) by Types (2013-2018)
Table Global Platinum based Cancer Drug Revenue Share by Types (2013-2018)
Figure Revenue Share of Platinum based Cancer Drug by Types (2013-2018)
Figure 2017 Revenue Market Share of Platinum based Cancer Drug by Types
Table Global Platinum based Cancer Drug Price (USD/Unit) by Types (2013-2018)
Figure Global Platinum based Cancer Drug Sales Growth Rate by Types (2013-2018)
Table Global Platinum based Cancer Drug Sales (K Unit) by Applications (2013-2018)
Table Global Platinum based Cancer Drug Sales Market Share by Applications (2013-2018)
Figure Global Platinum based Cancer Drug Sales Market Share by Applications (2013-2018)
Figure Global Platinum based Cancer Drug Sales Market Share by Applications in 2017
Figure Global Platinum based Cancer Drug Sales Growth Rate by Applications (2013-2018)
Table Sanofi Company Profile
Figure Platinum based Cancer Drug Product Picture of Sanofi
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2017-2018
Table Hengrui Medicine Company Profile
Figure Platinum based Cancer Drug Product Picture of Hengrui Medicine
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hengrui Medicine 2017-2018
Table ASK Pharma Company Profile
Figure Platinum based Cancer Drug Product Picture of ASK Pharma

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report